ライフサイエンスコーパス: racial

1 Racial and ethnic differences in associations between so

2 The review discusses possible causes of racial and ethnic disparities and also considers future

3 Given the prevalent racial and ethnic disparities in eye care and an increas

4 tical appraisal of the empirical research on racial and ethnic disparities in incidence, survival, an

5 the United States in 2014, with significant racial and ethnic disparities in infection rates.

6 Racial and ethnic disparities in patients with solid mal

7 Racial and ethnic disparities in the incidence of esopha

8 However racial and ethnic disparities seems to be a risk factor

9 The ASCO Strategic Plan to Increase Racial and Ethnic Diversity in the Oncology Workforce is

10 approved the ASCO Strategic Plan to Increase Racial and Ethnic Diversity in the Oncology Workforce.

11 d regions, and by cancer type, sex, age, and racial and ethnic group.

12 Clinical trials that include racial and ethnic groups need to confirm these findings.

13 her these associations are consistent across racial and ethnic groups.

14 eriod, particularly among youths of minority racial and ethnic groups.

15 haracterize and assess the representation of racial and ethnic minorities and women in randomized con

16 xhibits profound disparities in the USA with racial and ethnic minorities experiencing disproportiona

17 underlying persistent underrepresentation of racial and ethnic minorities in critical care fellowship

18 e need for support of parents, siblings, and racial and ethnic minority groups.

19 cisions made for their children with cancer, racial and ethnic minority parents are at heightened ris

20 ry of incarceration are more likely to be of racial and ethnic minority populations, poor, and have h

21 he past 50 years, research cohorts lack full racial and ethnic representation.

22 The observed geographical, racial and ethnic, age, sex, and temporal variations req

23 ed to achieve and maintain salary equity and racial and gender diversity at all levels.

24 n discharge practices between different sex, racial, and insurance-based strata.

25 e to non-SLE mortality, and significant sex, racial, and regional disparities persist.

26 INTERPRETATION: Racial assortativity is an inadequate explanation for ob

27 We modelled the ability for racial assortativity to generate or sustain disparities

28 ed a significant indirect effect of implicit racial bias on proprioceptive drift and magnitude of ill

29 reviews evidence on compounded deprivation, racial cleavages, civic engagement, institutional cynici

30 We then performed racial comparisons of positive and negative aspects of c

31 ttenuated nonsignificant association between racial composition in a neighborhood and survival.

32 on modeling examined the association between racial composition of neighborhoods and OHCA survival, a

33 resuscitation care and outcomes vary by the racial composition of the neighborhood where out-of-hosp

34 personnel on OHCA outcomes according to the racial composition of the neighborhood where the OHCA ev

35 est estimated noise exposures, regardless of racial composition.

36 To determine whether a racial difference exists in the relationship of mean glu

37 d other factors controlled for, the observed racial difference in 25(OH)D concentrations did not dimi

38 Further, 41% and 58% of the racial difference in CMB risk was explained by sleep tim

39 There was no racial difference in negative aspects of caregiving, dep

40 eighborhood SES explained 29% and 24% of the racial difference in the average rate of change in systo

41 Although racial difference in the distribution of intrinsic subty

42 There was little racial difference in unmet need for assistance.

43 No racial difference was found from vitamin D supplementati

44 There was no gender or racial difference.

45 ter clinical severity adjustment, gender and racial differences and hospital characteristics appear t

46 Historical racial differences and recent shifts in core demographic

47 s recommended SBP levels and to determine if racial differences exist based on long-term cognitive tr

48 Racial differences have been observed in IOP measurement

49 patients was attributable to elimination of racial differences in acute resuscitation survival (blac

50 has been largely mediated by elimination of racial differences in acute resuscitation survival and g

51 We aimed at evaluating racial differences in antihypertensive drug utilization

52 s into models, and to understand reasons for racial differences in behavioural reporting.

53 The findings show that racial differences in blood pressure among preterm child

54 In the current study, we examined racial differences in blood pressure trajectories across

55 Ethnic/racial differences in body composition and fat distribut

56 To investigate racial differences in breast cancer molecular features a

57 To examine if racial differences in Bruch's membrane opening minimum r

58 white/European American (EA) adults explain racial differences in cardiometabolic (CMB) disease risk

59 Racial differences in CHD incidence were attenuated amon

60 lth is therefore needed in efforts to reduce racial differences in CMB disease.

61 This was an exploratory study to assess the racial differences in dietary changes in relation to qua

62 nd Retirement Study (n = 34,757) to estimate racial differences in exposure to the death of family me

63 se of stroke; however, little is known about racial differences in ICAD prevalence and its risk facto

64 To determine racial differences in ICAD prevalence and the risk facto

65 Racial differences in outcomes associated with AF merit

66 These racial differences in outcomes narrowed but still persis

67 Racial differences in readmission hazard were assessed u

68 No racial differences in recurrence or survival were eviden

69 population-based REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

70 d enrolled in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort.

71 nd CHD among 9578 REasons for Geographic And Racial Differences in Stroke (REGARDS) study participant

72 based cohort, the REasons for Geographic and Racial Differences in Stroke (REGARDS) study, we evaluat

73 s enrolled in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

74 ve as the basis for examining geographic and racial differences in stroke risk and the incremental di

75 dy (CHS), and the Reasons for Geographic and Racial Differences in Stroke study (REGARDS) by sex.

76 ck REGARDS study (Reasons for Geographic and Racial Differences in Stroke) participants with (n=241)

77 ies) and REGARDS (Reasons for Geographic and Racial Differences in Stroke) studies.

78 d in the REGARDS (REasons for Geographic and Racial Differences in Stroke) study, a national prospect

79 he REGARDS study (Reasons for Geographic and Racial Differences in Stroke), the MESA (Multi-Ethnic St

80 he REGARDS study (Reasons for Geographic and Racial Differences in Stroke).

81 A substantial reduction in racial differences in survival after in-hospital cardiac

82 To examine whether racial differences in survival after in-hospital cardiac

83 rovide novel insights for the elimination of racial differences in survival for other conditions.

84 Whether racial differences in survival have narrowed as overall

85 mpared with white persons, possibly owing to racial differences in the glycation of hemoglobin.

86 persons are due to worse glycemic control or racial differences in the glycation of hemoglobin.

87 Racial differences in the prevalence and impact of GNB3

88 Objective: To determine if there are racial differences in the somatic mutation rate and gene

89 Long-standing racial differences in US life expectancy suggest that bl

90 These associations may help to explain racial differences in US stroke rates and offer insight

91 In contrast, no significant racial differences were found in the relationship of gly

92 en systematically reviewed in the context of racial differences.

93 rt studies did not or were unable to examine racial differences.

94 eal-world AF patient population and evaluate racial differences.

95 otypic MetS in genetic studies by minimizing racial differences.

96 iments further revealed that making societal racial discrimination salient increased the accuracy of

97 e totality of ways in which societies foster racial discrimination through mutually reinforcing syste

98 Racial disparities also persisted in subgroups stratifie

99 Substantial racial disparities exist in colorectal cancer (CRC) surv

100 f private well locations is unavailable; (2) racial disparities have perpetuated reliance on private

101 These results enrich our understanding of racial disparities in cancer and carcinogenic process.

102 The causes underlying racial disparities in cancer are multifactorial.

103 e contribution of sickle cell trait (SCT) to racial disparities in cardiopulmonary fitness is not kno

104 Racial disparities in cardiovascular disease mortality i

105 Racial disparities in colorectal cancer (CRC) persist, d

106 elucidated to define strategies for reducing racial disparities in community-associated MRSA rates.

107 entia risk and may be a major contributor to racial disparities in dementia.

108 nal risk factors that may be associated with racial disparities in diabetes incidence but have not si

109 We assessed racial disparities in early use of medications for commo

110 tional Transplant System did not exhibit the racial disparities in evaluation for KT as have been fou

111 More prospective research on racial disparities in health behavior changes after diag

112 These results suggest that racial disparities in health may persist in part because

113 om prevention research advances and decrease racial disparities in HIV rates.

114 A key to reduce and eradicate racial disparities in hypertension outcomes is to unders

115 observed association could, in part, explain racial disparities in incidence of ER- breast cancer.

116 rest to facilitate a better understanding of racial disparities in kidney transplantation.

117 We did not find racial disparities in ODX testing for node-negative pati

118 We examined racial disparities in ODX testing uptake.

119 Our regression analyses indicated no racial disparities in ODX uptake among node-negative pat

120 ss to care could substantially reduce ethnic/racial disparities in overall survival among nonelderly

121 m medical judgments, which may contribute to racial disparities in pain assessment and treatment.

122 the kinless population as well as increasing racial disparities in percentages kinless.

123 Whether there are racial disparities in survival of children with ESRD is

124 Racial disparities in the occurrence of DM, CKD, and HTN

125 Racial disparities in the prevalence of ID among both no

126 There were no significant racial disparities in the time to acceptance for KT [Log

127 t rates in the United States and substantial racial disparities in transplantation.

128 the molecular basis underlying the striking racial disparities of this disease, and represents a gen

129 g with these demographic changes, staggering racial disparities persist in health, wealth, and overal

130 Although ethnic/racial disparities related to hypertension and ICH have

131 ession were used to study the association of racial disparities with process of care and outcome meas

132 rapatient tacrolimus variabilities impact on racial disparities.

133 t neighborhood SES accounts for a portion of racial disparities.

134 Here, we overview the molecular basis of racial disparity in cancer susceptibility ranging from g

135 factors in young adulthood with the observed racial disparity in diabetes incidence between middle-ag

136 for type 2 diabetes and as a mediator of the racial disparity in diabetes risk.

137 for diabetes and may account for some of the racial disparity in diabetes risk.

138 ng prior to hospital discharge explained the racial disparity in infant mortality.

139 The racial disparity in invasive community-associated MRSA r

140 ities with either low transplant referral or racial disparity in referral.

141 tion analysis to determine the proportion of racial disparity mediated by socioeconomic factors.

142 value, and rural status, 91% of the original racial disparity was explained; no significant associati

143 There was a racial disparity with respect to disease type, with 38%

144 ich socioeconomic factors might explain this racial disparity.

145 er belief in a just world and social network racial diversity (among Black participants).

146 significantly associated with the degree of racial diversity (P < .001) within a study cohort: 30.0%

147 and differential dropout, limited ethnic and racial diversity, and differences in definitions of expo

148 ome White respondents tended to overestimate racial economic equality in the past, Black respondents,

149 Overestimates of current levels of racial economic equality, on average, outstripped realit

150 eased their tendency to overestimate current racial economic equality.

151 n average, underestimated the degree of past racial economic equality.

152 reduce the disparities in oral health across racial, ethnic and socioeconomic strata.

153 The United States has large racial, ethnic, and regional variation; we collected dat

154 Could this strategy reduce a portion of racial, ethnic, and socioeconomic achievement gaps for e

155 important opportunity to reach families from racial, ethnic, and socioeconomic groups who historicall

156 isplayed toward members of a particular sex, racial, ethnic, or religious group.

157 It is unclear whether racial/ethnic and income differences in foods and bevera

158 nd purchases of beverages from stores across racial/ethnic and income groups.

159 ough exposure variability showed significant racial/ethnic and regional differences, high exposure bu

160 Many studies have assessed racial/ethnic and sex disparities in the prevalence of e

161 sion and hypertension, as well as associated racial/ethnic and sex disparities.

162 We found evidence of racial/ethnic and socioeconomic differences in model-bas

163 We aimed to a) assess racial/ethnic and socioeconomic inequalities in noise po

164 tion of vitamin D status in women of diverse racial/ethnic backgrounds.A total of 301 women who under

165 s study aimed to determine whether there are racial/ethnic differences in 1-year adherence to AET and

166 SLE mortality risk and revealed significant racial/ethnic differences in associations of SLE mortali

167 or behavioral characteristics contribute to racial/ethnic differences in birthweight.

168 ventions focused on these factors may reduce racial/ethnic differences in lung cancer incidence and m

169 These racial/ethnic differences in obesity prevalence are like

170 ations and mortality with digoxin use but no racial/ethnic differences in outcomes were observed.

171 Racial/ethnic differences in palliative care resource us

172 recent data on the prevalence, severity, and racial/ethnic differences in pediatric obesity.

173 We aimed to determine whether there are racial/ethnic differences in resource utilization and in

174 There were significant racial/ethnic differences in spine BMD.

175 al mtDNAcn and add to literature documenting racial/ethnic differences in the psychological sequelae

176 2 years after detention, focusing on sex and racial/ethnic differences.

177 nd ectopic body fat measures did not explain racial/ethnic differences.

178 t on insurance coverage, access to care, and racial/ethnic disparities among adults with chronic dise

179 Our findings highlight racial/ethnic disparities among youth in achieving posit

180 008, 2011, and 2014 were used to examine how racial/ethnic disparities changed across time.

181 Racial/ethnic disparities exist in longer-term outcomes

182 Racial/ethnic disparities have been described in in-hosp

183 and whether out-of-pocket costs explain the racial/ethnic disparities in adherence.

184 Conclusion Racial/ethnic disparities in AET adherence were largely

185 Purpose Racial/ethnic disparities in cancer survival in the Unit

186 ent communication is associated with reduced racial/ethnic disparities in immediate PBR (IPBR).

187 Racial/ethnic disparities in preterm birth (PTB) are wel

188 on of the Blinder-Oaxaca method to decompose racial/ethnic disparities in PTB.

189 This study demonstrates decreased racial/ethnic disparities in the incidence of esophageal

190 Racial/ethnic disparities in the incidence of total esop

191 The influence of marital status on racial/ethnic disparities was stronger in men than in wo

192 sis tested the effect of the New York law on racial/ethnic disparities, using California as a compara

193 Reporting of both sex and racial/ethnic diversity of research cohorts is still lac

194 r lung cancer between 2000 and 2013 for each racial/ethnic group (non-Hispanic black, Hispanic, Asian

195 Age and racial/ethnic group disparities were addressed through t

196 The racial/ethnic group with the second most VI is projected

197 ence of food allergy and intolerance by sex, racial/ethnic group, and allergen group.

198 33 participants (78.7% response rate) from 3 racial/ethnic groups (Chinese [recruited from February 9

199 evels were compared between Asians and other racial/ethnic groups (white, black, Mexican American, an

200 substantially greater risk factor for all 3 racial/ethnic groups across all locations of ICH: whites

201 al trends in the representation of women and racial/ethnic groups across critical care fellowship typ

202 re often divided categorically into distinct racial/ethnic groups based on social rather than biologi

203 Admixture between racial/ethnic groups creates long-range linkage disequil

204 iles) as the predictor variable within the 4 racial/ethnic groups in the Multi-Ethnic Study of Athero

205 n in the incidence of early AMD exists among racial/ethnic groups in the United States and is not exp

206 004 to 2013, sepsis hospitalizations for all racial/ethnic groups increased, and mortality rates decr

207 ociated with incident early AMD across the 4 racial/ethnic groups was increasing age.

208 ities exist and can be modified among sexes, racial/ethnic groups, and geographic regions in US hospi

209 , and 58.6%, respectively) than males, other racial/ethnic groups, and residents of other regions, re

210 The rate of SCC decreased over time in all racial/ethnic groups, and this was most pronounced in bl

211 to 80% of risk-adjusted differences between racial/ethnic groups.

212 ic abnormality but normal weight (MAN) for 5 racial/ethnic groups.

213 can American individuals than in the other 4 racial/ethnic groups.

214 t daily fish and rice consumption across the racial/ethnic groups.

215 rsely associated with T2D overall and across racial/ethnic groups.

216 se of its low incidence, particularly across racial/ethnic groups.

217 iminate breast cancer disparities related to racial/ethnic identity and advance knowledge related to

218 t analysis to date of TNBC in the context of racial/ethnic identity and BBD as risk factors.

219 garding breast cancer disparities related to racial/ethnic identity, socioeconomic status, and tumor

220 amples of disparities in oncology related to racial/ethnic identity.

221 ty of studying breast cancer risk related to racial/ethnic identity.

222 utcome has well-documented correlations with racial/ethnic identity.

223 pants were white, and for many participants, racial/ethnic information was either not collected or no

224 in overweight or obese adults, older adults, racial/ethnic minorities (including Asian Americans), an

225 women (odds ratio, 0.81; 95% CI, 0.79-0.85), racial/ethnic minorities (odds ratio, 0.65; 95% CI, 0.61

226 ients (OR, 1.84; 95% CI, 1.24-2.73) or other racial/ethnic minorities (OR, 2.19; 95% CI, 1.16-4.11) h

227 s is limited by underuse, particularly among racial/ethnic minorities and individuals of low socioeco

228 individuals treated with in-center HD or PD, racial/ethnic minorities had a lower risk for death than

229 Although racial/ethnic minorities had greater improvements in som

230 female critical care fellows and those from racial/ethnic minorities were underrepresented in all ye

231 mes were greatest among women, older adults, racial/ethnic minorities, and individuals with lower edu

232 g subgroups, especially women, older adults, racial/ethnic minorities, and the socioeconomically disa

233 Although ESRD disproportionately affects racial/ethnic minorities, data on disparities in use and

234 Many in this group, particularly racial/ethnic minorities, lacked insurance coverage and

235 es and lower body weight, particularly among racial/ethnic minorities, we sought to determine whether

236 ever, reported rates may remain higher among racial/ethnic minorities.

237 rce reflect underrepresentation of women and racial/ethnic minorities.

238 on (DDKT) for highly sensitized patients and racial/ethnic minorities.

239 unction are well documented, but evidence in racial/ethnic minority children is lacking.

240 lic risk may result in a large proportion of racial/ethnic minority groups being overlooked.

241 Compared with whites, all racial/ethnic minority groups had a statistically signif

242 ander (106.4) and "other" (104.7; p < 0.001) racial/ethnic patients.

243 th a lower risk of colorectal cancer in most racial/ethnic subgroups.

244 gnosis had the greatest influence on overall racial/ethnic survival disparities accounting for 24% of

245 ociodemographic, and neighborhood factors to racial/ethnic survival disparities in California.

246 ercentage contribution of factors to overall racial/ethnic survival disparities was estimated from a

247 Conclusion Overall reductions in racial/ethnic survival disparities were driven largely b

248 Stage at diagnosis had the largest effect on racial/ethnic survival disparities, but earlier detectio

249 To estimate age, racial/ethnic, and sex-specific annual net transition pr

250 to PM-associated QT prolongation in a multi-racial/ethnic, genome-wide association study (GWAS).

251 eworthy finding because the narrowing of the racial gap in neighborhood poverty for blacks has gone l

252 By treating a specific cancer type and a racial group as an "experimental unit", driver mutation

253 C expansion is associated with reductions in racial group inequalities in mortality in Brazil.

254 th faster visual field progression in either racial group.

255 During the study period, all 3 racial groups (whites, blacks, and Hispanics) experience

256 ealth to the US population across ethnic and racial groups helps guide strategies to preserve vision

257 tions are differentiated (p < 0.05) over the racial groups in five cancers, such as lung adenocarcino

258 higher in the black population than in other racial groups in the United States.

259 ed with each cancer bear out differences for racial groups in the United States.

260 hepatitis B vertical transmission, but other racial groups show increasing rates due to hepatitis C a

261 Psoriasis is present in all racial groups, but in varying frequencies and severity.

262 e; however, if not equally accessible across racial groups, disparities in cancer care quality may pe

263 uctions in mortality amenable to PHC between racial groups.

264 death in the United States in all ethnic and racial groups.

265 ealth in the US population across ethnic and racial groups.

266 n and men, as well as for white and nonwhite racial groups.

267 uctant to identify racism as a root cause of racial health inequities.

268 on, even after accounting for differences in racial identity and socioeconomic status.

269 two objectives as well as evaluate disparate racial impacts.

270 results reveal an underappreciated layer of racial inequality in the United States, one that could c

271 lities in access along economic, gender, and racial lines persist.

272 ct was most pronounced among self-identified racial minorities and people with low income.

273 e guidelines is particularly challenging for racial minorities and youths from less affluent families

274 of age), male adults and youths, members of racial minorities, and members of sexual minorities gene

275 oma care for Medicaid recipients, especially racial minorities.

276 he generalizability of findings from TCGA to racial minorities.

277 continues to experience rapid growth in its racial minority population and is projected to attain so

278 Yet a half-century later, after war and racial-national extremism, the house lay in ruins and th

279 onic sleep restriction may "unmask" implicit racial or ethnic biases that are otherwise inhibited whe

280 ely within the United States reported on the racial or ethnic demographics of study participants.

281 white, black, and Hispanic women and lack of racial or ethnic disparities in persistence.

282 were defined as including a greater than 20% racial or ethnic minority participants based on US censu

283 % CI, 0.705-0.746): younger age; female sex; racial or ethnic minority; no history of hypertension, d

284 in D (25[OH]D) concentration, age, ethnic or racial origin, body-mass index, vitamin D dosing regimen

285 or in conjunction with scenarios of observed racial patterns in behavioural, care, and susceptibility

286 were significant risk factors across ethnic/racial populations (p-trends < 0.01).

287 The RNA splicing landscape of PCa across racial populations has not been fully explored as a pote

288 Racial prejudice is associated with a fundamental distin

289 hite patients with OHCA in each neighborhood racial quantile.

290 e, stratified by levels of metropolitan area racial residential segregation, classified using a multi

291 der the modifying role of metropolitan level racial residential segregation.

292 and highlight the importance of multiethnic/racial samples.

293 ing glucose, body mass index), neighborhood (racial segregation and tract-level poverty), psychosocia

294 Negative racial stereotypes tend to associate Black people with t

295 t how bodily states impact the expression of racial stereotyping.

296 recognizes that standard methods of defining racial subgroups are necessary to compare results across

297 ale) categorized faces varying in gender and racial typicality.

298 educational intervention may help to address racial variations in the use of TKR for the management o

299 nter ICH study (n = 261), and (3) the Ethnic/Racial Variations of Intracerebral Hemorrhage study (n =

300 The ERICH study (Ethnic/Racial Variations of Intracerebral Hemorrhage) is a pros